FIELD: medicine, pharmacy, chemical-pharmaceutical industry.
SUBSTANCE: invention relates to a medicinal formulation of tramadol with delayed-release. Proposed medicinal formulation possesses the high effectiveness in treatment of pains of different etiology and can be used in treatment of diseases chosen from the following group: enuresis, cough, inflammatory processes and/or allergic responses, depression states, abuse and/or alcoholism, gastritis, diarrhea, cardiovascular diseases, diseases of respiratory ways, psychic diseases, epilepsy.
EFFECT: improved and valuable medicinal and pharmaceutical properties of formulation.
38 cl, 11 tbl, 4 dwg, 11 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PERORAL MEDICINAL FORMULATIONS WITH SUSTAINED-RELEASE EFFECT | 2000 |
|
RU2240786C2 |
| TRAMADOL PHARMACEUTICAL SALTS | 2000 |
|
RU2292876C2 |
| PHARMACEUTICAL SALTS AND MEDICINAL AGENT | 2002 |
|
RU2309942C2 |
| COATED COMPOUND CONTAINING PHARMACEUTICAL AGENT | 2004 |
|
RU2372893C2 |
| METHOD FOR PREPARING SPHERICAL GRANULES | 2000 |
|
RU2221553C2 |
| ANALGESIC DRUG WITH SUSTAINED-RELEASING ACTIVE SUBSTANCE | 2000 |
|
RU2244541C2 |
| PROTECTED AGAINST UNADMINISTERED APPLICATION PERORAL MEDICATION FORM | 2005 |
|
RU2396944C2 |
| MEDICINE CONTAINING 3-(3-DIMETHYLAMINE-1-ETHYL-2-METHYLPROPYL) PHENOL WITH PROLONGED RELEASE OF REACTANT | 2002 |
|
RU2325905C2 |
| PHARMACEUTICAL FORMULATION WITH CONTROLLED-RELEASE ACTIVE SUBSTANCE | 2004 |
|
RU2447884C2 |
| ALCOHOL-RESISTANT DRUG COMPOSITIONS | 2019 |
|
RU2811409C2 |
